The future of brain health is shaped where minds gather, nature restores, and ideas take root.
Five summits a year at a single Berkshires estate. Forty seats each. Scientists, clinicians, builders, and backers, off the record, for long enough to matter.
Neuromodulation Summit · November 5–8, 2026 · The Thyme
Presented by Dragonfly 44 Capital, GFI Partners, and Cooley.
Invitations are being extended. Partnership and sponsorship opportunities remain.
Progress in brain health is a coordination problem.
The people who will define the next decade in autism, neurotechnology, neuroAI, psychedelics and psychoplastogens, and neurodegeneration rarely sit at the same table. Researchers need builders and funders. Founders need clinical context. Clinicians need better tools. Patients need science translated into care, faster.
The Berkshires Brain Summit exists to put those people at one table, off the record, for long enough to matter.
Forty seats, chosen one by one.
Every participant is invited or nominated. No tickets, no badges, no booths.
Everything off the record.
Sessions run under Chatham House-style norms. No recording, no attribution, no audience.
Built to end in action.
Collaborations, pilots, funding, and hires begin here. The summit is the start of the work, not the end of it.
- NeuromodulationThe instruments of the nervous system.November 5–8, 2026→
- Psychedelics and PsychoplastogensThe science and translation of lasting neural change.February 18–21, 2027→
- NeurodegenerationFrom lab to clinic in the diseases of the aging brain.April 22–25, 2027→
- NeuroAIWhere neuroscience meets machine intelligence.June 10–13, 2027→
- AutismResearch, care, and lived experience.Date shared→
Forty seats. Five summits. One rule: off the record.
"Berkshires Brain Summit was not to be missed. The format and environment leads to building deep and honest relationships with the other incredible leaders in attendance. We came away with game changing business opportunities and new perspectives. Highly recommend!"